HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

High intensity focused ultrasound (HIFU) is a novel, non-invasive treatment that is used to treat a wide range of tumors and diseases. HIFU uses an ultrasound transducer that has higher energy as compared to those used for diagnostic imaging. The transducer focuses on sound waves to generate heat at a single point within the body and destroys the target tissue. MRI images are used to plan the treatment and monitor the degree of heating in real time. Deep tissue penetration and thermal and mechanical interactions with human tissue are possible with ultrasound. With the development of high intensity focused ultrasound, a number of solid malignant tumors, such as those of the pancreas, liver, kidney, bone, prostate, and breast, as well as uterine fibroids and soft-tissue sarcomas, are clinically treatable. High intensity focused ultrasound and magnetic resonance imaging can be combined to provide real-time imaging during ablation. HIFU has advantages such as:

• It requires no surgical incisions into your body (it’s non-invasive) and doesn’t use radiation
• It can exactly target diseased tissue, leaving non-targeted healthy tissue unharmed
• It’s an outpatient procedure with a short recovery time. Patient can usual routine within a few days
• HIFU results in a quicker recovery than other, more invasive types of therapy in cancer treatment such as Radiation Therapy, Stem Cell Transplant among others

HIFU is also used in the treatment of facial aging. According to the American Board of Cosmetic Surgery, nonsurgical ultrasound treatments such as HIFU can:

• Tighten the skin on the neck
• Reduce the appearance of jowls
• Lift drooping eyelids or eyebrows
• Smooth wrinkles on the face
• Smooth and tighten chest skin

Market Dynamics

Increasing prevalence of rectal cancer is expected to drive the market growth over the forecast period. For instance, according to American Society of Clinical Oncology (ASCO), in May 2022, 732,210 people were diagnosed with rectal cancer in the year 2020.

Increasing number of research and development activities by research institutes is expected to drive the market growth over forecast period. For instance, Institute Mutualiste Montsouris, a General hospital in France, initiated a study to investigate the efficacy and safety of terbinumab combined with chemotherapy in neoadjuvant therapy of triple-negative breast cancer after HIFU therapy. The study is in phase 2 of clinical trials and is expected to complete by December 2024.

Key features of the study

• This report will provide in-depth analysis of the Global High Intensity Focused Ultrasound (HIFU) Market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It will elucidate potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global high intensity focused ultrasound (HIFU) market  based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Koninklijke Philips N.V.,  Sonic Concepts, Inc., Theraclion, Sonablate, Alpinion Medical Systems Co., Ltd., Shanghai Carnation Medical Technology Co., Ltd., Insightec, FUS Instruments Inc., Mianyang Sonic Electronic, Profound Medical, Merz Pharmaceuticals GmbH, Image Guided Therapy, and Promedica Bioelectronics s.r.l.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global high intensity focused ultrasound (HIFU) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global high intensity focused ultrasound (HIFU) market.

Market Segmentation

• Global High Intensity Focused Ultrasound (HIFU) Market, By Imaging Technology
  • Ultrasound- HIFU Therapy
  • Magnetic Resonance Imaging- HIFU Therapy
• Global High Intensity Focused Ultrasound (HIFU) Market, By Indication
  • Oncology
    • Prostate cancer
    • Rectal tumors
    • Liver tumors
    • Renal tumors
    • Others (Breast Cancer, Vaginal Cancer, etc.)
  • Skin Care
    • Anti-aging treatment
    • Skin Laxity and Tightening
    • Others (Jawline Enhancement, Eyelids or Eyebrows lifting, etc.)
  • Neurological Disorders
  • Others (Uterine Fibroids, Benign Prostatic Hyperplasia, etc.)
• Global High Intensity Focused Ultrasound (HIFU) Market, By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Dermatology Clinics
  • Others (Research Institutes, specialty Centers, etc.)
• Global High Intensity Focused Ultrasound (HIFU) Market, By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Company Profiles
  • Koninklijke Philips N.V.
  • Sonic Concepts, Inc.
  • Theraclion
  • Sonablate
  • Alpinion Medical Systems Co., Ltd.
  • Shanghai Carnation Medical Technology Co., Ltd.
  • Insightec
  • FUS Instruments Inc.
  • Mianyang Sonic Electronic
  • Profound Medical
  • Merz Pharmaceuticals GmbH
  • Image Guided Therapy
  • Promedica Bioelectronics s.r.l.